Placebo News and Research

RSS

Doping drug does little to improve cyclists' performance

Scientists in New Zealand say many top cyclists may be putting their health at risk for no competitive gain by taking the doping drug pseudoephedrine.

2 Jul 2009

Placebo effects in caregivers may change behavior of children with ADHD

Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder (ADHD) and improve their behavior.

29 Jun 2009

Researchers test whether estrogen could improve outcomes after traumatic brain injury, shock

UT Southwestern Medical Center researchers are conducting two pilot clinical trials to determine whether a single, early dose of estrogen can improve survival and neurological outcomes after severe traumatic brain injury or traumatic hemorrhagic shock.

29 Jun 2009

Cognitive behavioural therapy for major psychiatric disorder: does it really work?

Research co-led by an academic at the University of Hertfordshire, concludes that Cognitive Behavioural Therapy (CBT) is of no value in schizophrenia and has limited effect on depression.

28 Jun 2009

Golimumab shows promise for rheumatoid arthritis

Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet.

28 Jun 2009

How ‘high carb’ foods cause heart attacks

It has been commonly known for a number of years that certain foods, such as white bread and corn flakes, are bad for cardiac health, but new research from Israeli scientists shows just how 'high carb' foods cause heart attacks.

28 Jun 2009

Omega-3 fatty acids may protect against progression of age-related macular degeneration

Omega-3 fatty acids found in fatty fish such as tuna and salmon may protect against progression of age-related macular degeneration (AMD), but the benefits appear to depend on the stage of disease and whether certain supplements are taken, report researchers at the Laboratory for Nutrition and Vision Research (LNVR), Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University.

18 Jun 2009

New antioxidant supplement may help slow sight loss in elderly

Queen's University Belfast academics have helped develop an antioxidant supplement which may slow down sight loss in elderly people.

18 Jun 2009

Pneumococcal vaccine effective in preventing severe pneumonia

A new trial has found that pneumococcal vaccine is effective in preventing severe pneumonia, the leading cause of death among children in developing countries. Co-ordinated by the National Institute for Health and Welfare (THL) between 2000 and 2004, a large scale efficacy trial - first of its kind in Asia - was carried out in the Philippines to investigate the effect of an investigational pneumococcal vaccine.

16 Jun 2009

Depression may increase risk of Alzheimer's disease in people with memory problems

People with memory problems who are depressed are more likely to develop Alzheimer's disease compared to people who are not depressed, according to a study published in the June 16, 2009, print issue of Neurology, the medical journal of the American Academy of Neurology. However, the research also shows that the popular Alzheimer's drug donepezil may delay the progression to Alzheimer's disease for depressed people with mild cognitive impairment (MCI) or memory problems.

15 Jun 2009

Diabetes drug exenatide promotes weight loss when added to diet and exercise

In combination with diet and exercise, the diabetes drug exenatide helped nondiabetic, obese individuals lose over three times more weight than those receiving a placebo, or dummy treatment, for 6 months.

13 Jun 2009

Caffeine protects against increased risk-taking behavior during severe sleep deprivation

According to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, caffeine use prevents increased risk taking that occurs after several nights of total sleep deprivation.

10 Jun 2009

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.

9 Jun 2009

Light therapy as a treatment for sexual dysfunctions

Although we are still far from knowing exactly where and how the pineal suppressive role is exerted, the fact that the gland exerts an inhibitory function on the reproductive axis is widely accepted. In fact, the pineal seems to exert its hormonal effect at different levels of the reproductive axis, both at the hypothalamic-pituitary level and at the gonadal level, where melatonin receptors have also been found.

9 Jun 2009

Botox injections can help overactive bladders sufferers

Botox is well known for its cosmetic uses, but researchers have now found that it can also significantly improve people's quality of life if they suffer from another problem that increases with age, an overactive bladder (OAB).

9 Jun 2009

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

5 Jun 2009

Experimental drug five times more effective against MDR-TB than conventional therapy

A Johnson & Johnson-run study found that its experimental drug TMC207 could make conventional tuberculosis treatment five times more effective against multi-drug resistant TB (MDR-TB) because it cleared traces of the TB bacteria in the sputum of 48 percent of study volunteers after eight weeks, Reuters reports (Emery, Reuters, 6/3). The results were published on Wednesday in the New England Journal of Medicine.

4 Jun 2009

British researchers call for WHO to 'condemn homeopathy' for serious diseases

British researchers on Monday requested the WHO "publicly condemn homeopathy as a treatment for serious diseases, such as HIV/AIDS, TB and malaria," amid growing concern that some patients are dying as a result of choosing homeopathy over effective medicines, the Mail & Guardian reports. "The WHO works with national organisations that promote homeopathy and other alternative medicines in their public health programmes," according to the Mail & Guardian.

2 Jun 2009

Vandetanib shows clinical benefit when combined with docetaxel for lung cancer

When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.

1 Jun 2009

Citalopram no more effective than a placebo for children with autism spectrum disorders

Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.

1 Jun 2009

Placebo News and Research

Doping drug does little to improve cyclists' performance

Placebo effects in caregivers may change behavior of children with ADHD

Researchers test whether estrogen could improve outcomes after traumatic brain injury, shock

Cognitive behavioural therapy for major psychiatric disorder: does it really work?

Golimumab shows promise for rheumatoid arthritis

How ‘high carb’ foods cause heart attacks

Omega-3 fatty acids may protect against progression of age-related macular degeneration

New antioxidant supplement may help slow sight loss in elderly

Pneumococcal vaccine effective in preventing severe pneumonia

Depression may increase risk of Alzheimer's disease in people with memory problems

Diabetes drug exenatide promotes weight loss when added to diet and exercise

Caffeine protects against increased risk-taking behavior during severe sleep deprivation

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight

Light therapy as a treatment for sexual dysfunctions

Botox injections can help overactive bladders sufferers

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

Experimental drug five times more effective against MDR-TB than conventional therapy

British researchers call for WHO to 'condemn homeopathy' for serious diseases

Vandetanib shows clinical benefit when combined with docetaxel for lung cancer

Citalopram no more effective than a placebo for children with autism spectrum disorders

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News